Investigation of female survival benefit in metastatic melanoma
1999

Female Survival Benefit in Metastatic Melanoma

publication Evidence: moderate

Author Information

Author(s): Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller J G, Neil S Mac

Primary Institution: University Department of Medicine and Departments of Clinical Chemistry and Plastic and Reconstructive Surgery, Northern General Hospital Trust, Sheffield, S5 7AU, UK

Hypothesis

The study investigates the relationship between sex steroids and the progression of cutaneous melanoma.

Conclusion

The study found that sex steroids may play a role in melanoma progression, with oestrone being particularly potent in inhibiting cell invasion.

Supporting Evidence

  • The study reports a significant reduction in circulating oestrone with disease progression in male but not female patients.
  • Oestrogenic compounds were found to inhibit invasion of melanoma cells, with oestrone being approximately 50 times more potent than 17β-oestradiol.
  • Steroids lacking the benzene ring structure did not inhibit invasion and some enhanced it.

Takeaway

This study looks at how hormones might affect the growth of melanoma, a type of skin cancer, and found that some hormones can help slow down the cancer's spread.

Methodology

The study examined the relationship between circulating sex steroids and disease progression, the ability of steroids to reduce invasion of melanoma cells in vitro, and the effects of sex steroids on cell proliferation.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690637

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication